Telesis bio stock.

TBIONasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Healthcare Equipment & Supplies. TELESIS BIO INC. (TBIO).Revenue for the September 30, 2023 year-to-date period of $20.5 million was $2.6 million, or 14.3% ahead of the prior year. Gross margin at 53.9% for the third quarter was slightly below the same period last year at 54.8% due to reduced high margin collaboration/other revenue. However, for the nine-months ended September 30, 2023, …Telesis Bio Inc (NASDAQ:TBIO) showed a performance of -61.05% in past 30-days. Number of shares sold short was 0.32 million shares which calculate 14.15 days to cover the short interests. Wall Street analysts have assigned a consensus price target of $4.00 to the stock, which implies a rise of 90.75% to its current value.Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system, including BioXp 3250 system, BioXp 9600 system, and BioXp DBC, which are empowers ...SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced ...

13 Nov 2023 ... SAN DIEGO (AP) — SAN DIEGO (AP) — Telesis Bio, Inc. (TBIO) on Monday reported a loss of $10.6 million in its third quarter.

May 22, 2023 · SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its BioXp ® Select DNA Cloning kit. The BioXp® Select DNA Cloning kit enables on-demand and automated assembly of DNA fragments via Gibson Assembly ... The latest price target for . Telesis Bio (NASDAQ: TBIO) was reported by Keybanc on August 11, 2023.The analyst firm set a price target for $0.00 expecting TBIO to fall to within 12 months (a ...

SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced ...Telesis Bio, Inc. (TBIO) is a leader in automated multi-omic and synthetic biology solutions. The stock price, news, quote and history of the company are available on Yahoo Finance. See the latest performance outlook, earnings date, dividend yield, analyst report and more. Find the latest 89bio, Inc. (ETNB) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 13, 2023 · SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the third ... SAN DIEGO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the second ...

Shares of Telesis Bio, Inc. (TBIO Quick Quote TBIO - Free Report) have soared 77.9% since it was upgraded to a Zacks Rank #2 (Buy) on February 2. ... This stock-rating system, ...

Stock Trading Strategies All; America; Europe; Asia; Our Shows Shows Strategy Must Watch Satirical Cartoon Today's Editorial Crypto Recap Behind the numbers Stock Picks ... Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks …

SAN DIEGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter ...This could make Telesis Bio Inc less attractive for value investors when compared to the industry median at 2.11. You can read more about Telesis Bio Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system, including BioXp 3250 system, BioXp 9600 system, and BioXp DBC, which are empowers ...28 Jun 2023 ... The securities purchase agreement provides Telesis Bio with $28 million in initial upfront funding through the private placement of redeemable ...Nov 29, 2023 · Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today ...

About Telesis Bio Telesis Bio Inc. is building biology. Creators of the BioXp® system, the world’s only fully automated gene synthesis platform, and the industry-standard Gibson Assembly® method, Telesis Bio Inc. is focused on enabling researchers with the tools they need to rapidly and securely design, code, and create synthetic DNA.ReShape Lifesciences Inc stock has a Value Grade of B. Telesis Bio Inc stock has a Value Grade of A. Tivic Health Systems Inc stock has a Value Grade of B. Now that you have a bit more background about each of the 3 undervalued stocks in the Advanced Medical Equipment & Technology industry as well as their overall grades, it’s …About Telesis Bio Telesis Bio Inc. is building biology. Creators of the BioXp® system, the world’s only fully automated gene synthesis platform, and the industry-standard Gibson Assembly® method, Telesis Bio Inc. is focused on enabling researchers with the tools they need to rapidly and securely design, code, and create synthetic DNA.Telesis Bio Inc (TBIO) has been making waves in the stock market recently, with analysts predicting a significant increase in its stock price. According to data from CNN Money, the 1 analyst offering 12-month price forecasts for TBIO has a median target of $4.00, representing a staggering 699.84% increase from the last price of $0.50.SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2023 financial results on Monday, November 13, 2023, after the market closes. The press release can be accessed via the Investor section of Telesis Bio ... Discover historical prices for TBIO stock on Yahoo Finance. View daily, weekly or monthly format back to when Telesis Bio, Inc. stock was issued.

Legal Name Telesis Bio Inc. Stock Symbol NASDAQ:TBIO. Company Type For Profit. Contact Email [email protected]. Phone Number +1 855-474-4362. Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA. Telesis Bio was founded in 2013 and was …SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced its speaker lineup for presentations at SynBioBeta’s Built with Biology Global Conference, which is being held in Oakland, Calif., on April 12-14, 2022. Codex DNA will be showcasing its …

Dec 1, 2023 · Telesis Bio, Inc. (NASDAQ:DNAY) issued its quarterly earnings results on Monday, November, 8th. The company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by $0.06. The firm earned $2.79 million during the quarter, compared to analyst estimates of $2.93 million. SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced ...Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of ...Legal Name Telesis Bio Inc. Stock Symbol NASDAQ:TBIO. Company Type For Profit. Contact Email [email protected]. Phone Number +1 855-474-4362. Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA. Telesis Bio was founded in 2013 and was …A short bio should include an introduction, information about education, relevant information regarding awards and achievements, and a conclusion. Depending on the purpose of the bio, it may also include relevant work experience and qualifi...Telesis Bio, Inc. 0.3999. +0.0998. +33.26%. Telesis Bio, Inc. (NASDAQ:TBIO) Q4 2022 Earnings Call Transcript March 25, 2023 Operator: Good day, and thank you for standing by, and welcome to the Q4 ...

Jun 22, 2022 · Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of ...

Telesis Bio. November 8, 2022 at 4:10 PM · 8 min read. Telesis Bio. -- Record revenue of $6.7M in 3QFY22; Increase of 140% over $2.8M 3QFY 2021. -- BioXp® Kit Revenue increased to $884k, or 69% ...

Item 5.07 Submission of Matters to a Vote of Security Holders. On June 9, 2022, Codex DNA, Inc. held its 2022 Annual Meeting of Stockholders. Of the 29,398,463 shares of common stock outstanding...Telesis Bio, Inc. (TBIO) is a leader in automated multi-omic and synthetic biology solutions. The stock price, news, quote and history of the company are available on Yahoo Finance. See the latest performance outlook, earnings date, dividend yield, analyst report and more. A short bio should include an introduction, information about education, relevant information regarding awards and achievements, and a conclusion. Depending on the purpose of the bio, it may also include relevant work experience and qualifi...Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building …Have you ever been asked to write a short bio about yourself and found yourself struggling to capture your essence in just a few sentences? Don’t worry, you’re not alone. The first step in writing an attention-grabbing short bio is to start...TELESIS BIO INC (NASDAQ: TBIO) ; Yesterday's Close. 0.40. open. 0.00. volume. 1.64 M ; 1 day. 0.00 · 52 weeks. 0.30 · p/e. 0.00 ; market cap. 0.01 B · dividend yield.Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system, including BioXp 3250 system, BioXp 9600 system, and BioXp DBC, which are …Sep 19, 2022 · Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of ... Telesis Bio (TBIO) - A biotech Co engaged in the development of automation solutions for DNA, RNA, and protein synthesis. GROUP LEADERSHIP Medical-Research Eqp/Svc Group. TBIO. is not ranked # N/A. in group MEDP. is ranked # 1. 1 st in group. ... Translate Bio Stock Rockets As Sanofi Jumps Into mRNA Technology With $3.2 Billion Takeover …Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock June 05, 2023 17:30 ET | Source: Telesis BioReal time Telesis Bio (DNAY) stock price quote, stock graph, news & analysis.SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced the closing of its private placement of redeemable convertible preferred stock and warrants resulting in initial gross proceeds of $28.0 million to ...

SAN DIEGO, April 27, 2022 -- Codex DNA, Inc. , a pioneer in automated benchtop synthetic biology systems, today announced its speaker lineup for presentations at the PEGS Boston Conference and...Codex DNA, Inc. announced its speaker lineup for Antibody Engineering & Therapeutics Europe, which is being held on June 7-9, 2022 in Amsterdam and online. The company will be showcasing its automated...Get the LIVE share price of Translate Bio(TBIO) and stock performance in one place to strengthen your trading strategy in US stocks.On July 20, 2022, the Board of Directors of Codex DNA, Inc. approved the expansion of the Board from six to seven members and appointed Annette Tumolo to serve as a Class III director, effective immediately, with a term expiring at the 2024 annual meeting of stockholders or until her successor has been duly elected and qualified.Instagram:https://instagram. unlocked phones black fridaykennedy half dollar pricesmfs total return fund anvr ticker Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you. older quarters worth moneynetdu stock Telesis Bio. November 8, 2022 at 4:10 PM · 8 min read. Telesis Bio. -- Record revenue of $6.7M in 3QFY22; Increase of 140% over $2.8M 3QFY 2021. -- BioXp® Kit Revenue increased to $884k, or 69% ... best communication books Telesis Bio Inc. stock performance at a glance. Check Telesis Bio Inc.’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.Telesis Bio is home to Gibson Assembly, and pioneering synthetic DNA/gene synthesis hardware, including the BioXp, the world’s first DNA printer. Our mission is to empower scientific researchers in both academic and commercial settings with the materials and methods to rapidly and accurately write large quantities of synthetic genes.Jun. 29, 2021 at 10:22 a.m. ET by Barron's. Biotech and Pharma Covid-19 Showed mRNA Vaccines Work. Translate Bio, Sanofi, Are Testing One for Flu. Jun. 22, 2021 at 9:01 …